Napp Pharmaceuticals: Difference between revisions
New |
(No difference)
|
Revision as of 14:00, 6 March 2019
Napp Pharmaceuticals Limited is a private pharmaceutical in Cambridge, United Kingdom, that was founded in 1923.[1] It was bought in 1966 by the Sackler brothers.[2] As a sister company of Purdue Pharma and Mundipharma it is owned by the descendants of Mortimer Sackler and Raymond Sackler. The company produces an array of pharmaceutical products, many for pain management, among them Oxycodone and its derivatives that have been identified as key drugs in the opioid epidemic.[3][4]
In the early 1970s scientists at Napp developed a delivery system whereby a pill would be continuously delivering a drug over a 12 hour period.[5] This "Contin" delivery system was used by Purdue first to introduce MS Contin in 1987 and Oxycontin eight years later.
On June 11, 2018 seven members of the Sackler family stepped down from their seats at the Board of Directors.[2]
External links[
References
- ^ Glassdoor.com listing
- ^ a b Steve Birr (July 18, 2018). "Sackler Clan Resigns From Board Of Directors For The British Arm Of Their Opioid Empire". The Daily Caller. Retrieved March 6, 2019.
- ^ Rebecca L. Haffajee, Michelle M. Mello (December 17, 2017). "Drug Companies' Liability for the Opioid Epidemic". New England Journal of Medicine. Retrieved March 6, 2019.
- ^ David Armstrong (February 21, 2019). "Sackler Embraced Plan to Conceal OxyContin's Strength From Doctors, Sealed Testimony Shows". ProPublica. Retrieved February 27, 2019.
- ^ David Crowe (September 8, 2018). "What next for the Sacklers? A pharma dynasty under siege". Financial Times. Retrieved February 24, 2019.